— Know what they know.
Not Investment Advice

BIMI OTC

BIMI International Medical Inc.
1W: -50.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±206.4%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Medical - Distribution · Tech Score Neutral · Power 56 · $2792 mcap · 14M float · 0.0053% daily turnover · Short 61% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.000500000024
Volume26,254
Avg Volume738
Beta-0.51
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTiewei Song
Employees296
SectorHealthcare
IndustryMedical - Distribution
IPO Date2006-10-18
725 5th Avenue
New York, NY 10022
US
86 23 6310 7239
About BIMI International Medical Inc.

BIMI International Medical Inc., headquartered in Chongqing, China, is an enterprise engaged in a diverse array of healthcare operations. The company, which was established in 2000 and adopted its current name in June 2021 (formerly BOQI International Medical Inc.), focuses on the supply and sale of medical devices, pharmaceuticals, and other health-related products. Its business activities are structured across four main divisions: wholesale pharmaceuticals, wholesale medical devices, medical services, and retail pharmacies. For its wholesale segment, BIMI distributes a wide range of specialized medical equipment, including Stryker spinal products, Olympus endoscopes, various imported imaging devices, and diagnostic imaging systems. These products are supplied to clients such as drugstores, private clinics, pharmaceutical dealers, and hospitals, particularly within China's Southwest region. The company also facilitates the distribution of a broad spectrum of pharmaceutical products, comprising generic medications, traditional Chinese herbal remedies, biochemical drugs, essential raw ingredients for pharmaceuticals, antibiotics, cardiovascular treatments, and anti-obesity medicines. Through its "Lijiantang Pharmacy" brand, BIMI operates a network of directly-owned retail outlets. These pharmacies offer consumers an extensive selection of items, including prescription and over-the-counter drugs, nutritional supplements, health foods, sundry goods, traditional Chinese medicines, personal and family care products, and medical devices. Beyond product sales, BIMI also delivers medical services within hospital environments and undertakes IT research and development initiatives.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Tiewei Song S-Sale 4,000 $4.08 2024-02-28
Tiewei Song S-Sale 724 $4.01 2024-02-26
Smith Symington Wei 0 — 2023-12-29
Oudom Fnu A-Award 214,044 $1.20 2023-12-28
Oudom Fnu A-Award 200,000 $1.20 2023-12-28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms